Central modulation of pain
GLP-1 patches would be developed primarily for type 2 diabetes mellitus and obesity management, working through improved glycaemic control, reduced appetite, increased satiety, and delayed gastric emptying, similar to current injectable GLP-1 medications
Semaglutide and other GLP-1 receptor agonists are highly effective for weight management, but emerging clinical reports suggest they may increase photosensitivity in some patients
The FDA is reconsidering its decision to remove Eli Lillys drugs, Zepbound and Mounjaro, from the shortage list, temporarily allowing compounding facilities to continue producing alternative versions
The real issue is something less obvious: dehydration-amplified sun damage
Managing Stress: High stress can disrupt progress